Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. - Wikidata - wikimedia - TriplyDB

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

http://www.wikidata.org/entity/Q35126237

about

Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis Acute Myeloid Leukemia: A Concise Review Monitoring minimal residual disease in acute myeloid leukaemia: a review of the current evolving strategies Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance Genomic Classification and Prognosis in Acute Myeloid Leukemia.Aberrant splicing and drug resistance in AML Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia.Prior cytopenia predicts worse clinical outcome in acute myeloid leukemia.Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia Individualizing Therapeutic Strategies in Acute Myeloid Leukemia: Moving Beyond the 'One-Size-Fits-All' Approach.Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms.Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.Normal vs. Malignant hematopoiesis: the complexity of acute leukemia through systems biology.Alkylator-Induced and Patient-Derived Xenograft Mouse Models of Therapy-Related Myeloid Neoplasms Model Clinical Disease and Suggest the Presence of Multiple Cell Subpopulations with Leukemia Stem Cell Activity Cohesin loss alters adult hematopoietic stem cell homeostasis, leading to myeloproliferative neoplasms Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia.Cancer susceptibility genes and their potential implication regarding systemic therapy for early-stage breast cancer.Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML.Histone demethylase KDM2B regulates lineage commitment in normal and malignant hematopoiesis.Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification.Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins.Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS.Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation.The new provisional WHO entity 'RUNX1 mutated AML' shows specific genetics but no prognostic influence of dysplasia.RNA splicing factors as oncoproteins and tumour suppressors.A proteomic analysis of acute leukemia cells treated with 9-hydroxyoctadecadienoic acid.TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes Dissociation of Survival, Proliferation, and State Control in Human Hematopoietic Stem Cells.Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.Preleukemia: one name, many meanings.Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies.Immunohistochemical loss of 5-hydroxymethylcytosine expression in acute myeloid leukaemia: relationship to somatic gene mutations affecting epigenetic pathways.The clonal origins of leukemic progression of myelodysplasia.Isolated trisomy 13 in refractory anemia with excess blasts: report of two cases and a brief literature review of this possible association.Diagnosis and Therapy of Acute Myeloid Leukemia in the Era of Molecular Risk Stratification.Therapy-related myeloid neoplasms: when genetics and environment collide.Molecular Malfeasance Mediating Myeloid Malignancies: The Genetics of Acute Myeloid Leukemia.

P2860

Q26752221-E42C94D9-84B0-4B02-B9D3-EC2DD6740CB0 Q26766719-40DF11A2-3767-4308-B15B-F784B6E78E29 Q26770394-793BFF74-CC48-4089-97BF-9269E2FE2BC1 Q26776393-A313CE3A-35DE-46A7-993C-86EAE562DB81 Q27853389-1ECF8661-4121-48EC-A1AE-CFB2D8EA4FC5 Q28076011-5CEB5485-C44E-44AD-A835-7473BEDFF62A Q30313615-FBE6D44D-09A9-4315-9D00-008720483E7A Q33424807-106AE3AB-4845-47DB-A094-80DBB6BD64CE Q33615619-03BE72C4-2761-49C9-A949-0992F104478A Q33796552-16C1DB49-36C1-477E-B3BC-D7C63F9353F2 Q33865370-1734A72C-AEEA-49B9-B20F-BF8FA7F4A054 Q34047259-4B3060DC-61CF-4B34-BFEE-AD492F5AFFE2 Q34548829-69158F0B-E51C-4397-9897-13F65946E2A2 Q36049172-A856E591-5D0B-4817-9474-613487743C3F Q36080036-A986723F-C9D9-48C9-B0EF-0C150CF81E01 Q36180677-73B374F5-8023-407A-B47D-8E6697A50628 Q36208652-BA1366C9-879A-4CD4-8E69-7EBFC3228897 Q36450218-AB1E73F6-F2D2-4E96-8825-EDD4067C1FDE Q36596887-CF175E6D-F04E-4DA2-AED1-E4332AECA427 Q36618609-BCC420C8-C0B3-46C6-97CD-F9F8BACF38BA Q36804633-A0F2EEE8-E25C-429B-8067-B13013471D4E Q36849666-19DBCCC2-7256-43F8-8E57-9FB2B612F6D3 Q36962514-4F612F3A-9AC8-44E5-8741-92E34B84A8B1 Q36984373-B9B15383-23EC-4AF1-8D06-B4702220E4F2 Q37046592-94C67B74-13B6-42EB-9387-C198D9C33436 Q37216267-E6554976-4011-4414-91D5-F9B826B2D38C Q37324981-89B4C499-A314-4420-80BB-65CE2DC49434 Q37391660-B4CFE798-B39F-4FBD-AA9F-B7611189F154 Q37408874-32DD2249-178B-4305-8CBD-57C1BD3C5AFC Q37566878-0FE142CF-C35B-4A92-84E7-688731DFD174 Q37583700-30E69321-EEB1-431A-9810-F78B7CBCA134 Q37624593-CA3377D4-8B77-4229-94B2-67F4169B82EC Q37683379-7F81EAE3-BE76-4654-8FA5-8824007BEE21 Q37699158-4ECBEE02-CE07-4038-9D64-6F76994FDE55 Q38379074-AE9BD8B6-4242-4215-8DB2-0376708403B8 Q38406756-8596E8C3-603C-4BA8-8E6F-0B159621B1C9 Q38541690-4B134A15-FE5B-4326-B1B5-62008F49DD10 Q38608903-A5D794FD-9247-4CF4-9C50-7C1CC404D20A Q38611096-C95E0B95-09B7-4767-9FA7-D37DA045B4E9 Q38653160-F69E06FF-E60F-49BE-8090-9B6EDBAAD2F9

P2860

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

http://www.wikidata.org/entity/Q35126237

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

@ast

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

@en

type

label

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

@ast

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

@en

prefLabel

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

@ast

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

@en

P1433

Q35126237-A9A54397-082E-4D2D-8317-D3AC694886CE

P1476

Q35126237-4F277908-F3C4-4F8E-8D32-B4EB4614AF68

P2093

Q35126237-07B8DB6D-83B7-48F3-889B-2CD61D1C3ECF

Q35126237-333EE24C-561B-4B30-A3F6-8B3347E3D98E

Q35126237-36D1777D-6275-4E2D-9462-F83F82BACE7A

Q35126237-4B61D634-37FC-409C-95A2-F83E385DA848

Q35126237-5812286C-0D64-4667-9E9D-93FC9C9D4F30

Q35126237-6110747D-768B-4ABB-A907-2575E0B3AECE

Q35126237-8238F023-3554-4012-BD2C-C982E5082C32

Q35126237-85B28CB2-EFB5-493D-8EA2-58BC4F7A5FED

Q35126237-85F45B7A-EA40-4D22-B125-FCB476441433

Q35126237-87035AC5-62F9-4722-91B0-2806A5E1A27F

P2860

Q35126237-02488747-BF4D-48AD-BF26-45E70BD0E9D1

Q35126237-121F30D5-5640-4857-BAAD-08E726BE3242

Q35126237-13ED4DD5-5F6D-4680-A4ED-43B5739F87BC

Q35126237-197327B5-C05C-43CD-AC9E-E43B74118D5B

Q35126237-27BBADD6-6049-49CB-BC9B-7AB7A684FB2F

Q35126237-28912397-5A04-4032-BD81-65970A4D7E0D

Q35126237-3F5D9B7D-50E2-4158-A1A2-5698F87FB9B1

Q35126237-4AC66C82-9AD9-425E-9B4D-2FA25C71E6C0

Q35126237-5AA07E3B-B342-4698-AD89-15E0F545D244

Q35126237-5B7A60EB-EAA7-4421-B8AC-7536E80FD068

P304

Q35126237-4DBC6DB3-D05A-4599-943E-B1CF57B50250

P31

Q35126237-797DC805-811F-44F2-BBFB-DF68F5535632

P356

Q35126237-B0687A5B-4205-4E16-A8D2-69B8D4FAE48E

P407

Q35126237-2EC6D994-7BAB-4F91-B277-94B4B3F3ACFB

P433

Q35126237-57D79370-CDD5-4E20-90BE-9471E71979AF

P478

Q35126237-A1F9ADE4-021F-4E63-8C76-21053907C06F

P50

Q35126237-AD3A5BBB-5A6D-42F2-847B-D98E2203DA16

Q35126237-C4BF3E1F-2C5F-4B22-A2CD-F96E42AFF205

P577

Q35126237-0F6AA96A-4563-4500-BA89-BD18CDCADFBC

P5875

Q35126237-BC462057-0E26-47BB-81E4-433F4276FE46

P698

Q35126237-31F07040-1563-4ED2-8E46-1C136653F869

P921

Q35126237-93196290-9D48-47F8-9401-6DC94BAFEB47

P932

Q35126237-9E2180E7-EA07-4F5B-95FF-72EE5AE4843E

P356

BLOOD-2014-11-610543

P1433

P1476

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

@en

P2093

Arnaud Pigneux

http://www.w3.org/2001/XMLSchema#string

Bayard L Powell

http://www.w3.org/2001/XMLSchema#string

Benjamin L Ebert

http://www.w3.org/2001/XMLSchema#string

Daniel J DeAngelo

http://www.w3.org/2001/XMLSchema#string

David P Steensma

http://www.w3.org/2001/XMLSchema#string

Donna Neuberg

http://www.w3.org/2001/XMLSchema#string

Emanuele Mazzola

http://www.w3.org/2001/XMLSchema#string

Harry P Erba

http://www.w3.org/2001/XMLSchema#string

Lloyd E Damon

http://www.w3.org/2001/XMLSchema#string

Martha Wadleigh

http://www.w3.org/2001/XMLSchema#string

P2860

An integrated map of genetic variation from 1,092 human genomes

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

The Catalogue of Somatic Mutations in Cancer (COSMIC)

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence

Age-related clonal hematopoiesis associated with adverse outcomes

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing

New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants.

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.

P304

1367-1376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2014-11-610543

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270343401

http://www.w3.org/2001/XMLSchema#string

P698

25550361

http://www.w3.org/2001/XMLSchema#string

P921

P932

4342352

http://www.w3.org/2001/XMLSchema#string